Eton Pharmaceuticals, Inc. - stock earnings
ETON Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -2.3 million USD | 7.3 million USD |
2023Q3 | -579000 USD | 7.0 million USD |
2023Q2 | 4.6 million USD | 12.0 million USD |
2023Q1 | -2.9 million USD | 5.3 million USD |
2022Q4 | 912000 USD | 8.5 million USD |
2022Q3 | -3.2 million USD | 3.2 million USD |
2022Q2 | -1.8 million USD | 7.4 million USD |
2022Q1 | -5.6 million USD | 2.2 million USD |
2021Q4 | 1.0 million USD | 6.1 million USD |
2021Q3 | -6.1 million USD | 775000 USD |
2021Q2 | -2.0 million USD | 3.1 million USD |
2021Q1 | 5.1 million USD | 11.9 million USD |
2020Q4 | -7.7 million USD | 81000 USD |
2020Q3 | -6.5 million USD | -161000 USD |
2020Q2 | -4.7 million USD | 20000 USD |
2020Q1 | -9.0 million USD | 99000 USD |
2019Q4 | -2.7 million USD | 459000 USD |
2019Q3 | -5.0 million USD | ? USD |
2019Q2 | -3.2 million USD | ? USD |
2019Q1 | -7.4 million USD | 500000 USD |
2018Q4 | -3.7 million USD | ? USD |
2018Q3 | -2.9 million USD | ? USD |
2018Q2 | -3.1 million USD | ? USD |
2018Q1 | -3.0 million USD | ? USD |
2017Q4 | -7.9 million USD | ? USD |
2017Q3 | -2.8 million USD | ? USD |
2017Q2 | -2.2 million USD | ? USD |
ETON Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -936000 USD | 31.6 million USD |
2022 | -9.8 million USD | 21.3 million USD |
2021 | -3.0 million USD | 21.8 million USD |
2020 | -28.8 million USD | 39000 USD |
2019 | -18.0 million USD | 959000 USD |
2018 | -12.7 million USD | ? USD |
2017 | -10.7 million USD | ? USD |
ETON
Price: $3.45
52 week price:
Earnings Per Share: -0.04 USD
P/E Ratio: -449
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 36257
Market Capitalization: 92.2 million